Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 26.80
+0.40 (1.52%)
At close: Jun 26, 2026
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of €1.38 billion as of June 26, 2026. Its market cap has decreased by -11.46% in one year.
Market Cap
1.38B
Enterprise Value
1.02B
Revenue
358.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€26.80
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from 1.49B to 1.38B, a decrease of -7.75%. That is a compound annual growth rate of -1.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.38B | -7.80% |
| Dec 31, 2025 | 1.49B | 4.78% |
| Dec 31, 2024 | 1.43B | -53.35% |
| Dec 29, 2023 | 3.06B | 19.45% |
| Dec 30, 2022 | 2.56B | 93.80% |
| Dec 31, 2021 | 1.32B | -11.59% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Darwin AG | 95.40M |
| 2invest AG | 44.96M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 24.99M |
| co.don AG | 414.21K |
| Paion AG | 385.22K |
| bioXXmed AG | 222.93K |